Vanderbilt team to test lasso peptides for ovarian cancer
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
A new study establishes a robust manufacturing process for Ga-DOTA-4AH29, enabling both automated and manual clinical production of a PET ...
Researchers have validated an automated, high-yield radiosynthesis protocol for gallium-68-labelled NODAGA-exendin-4 across multiple generator systems to support routine clinical detection ...
The Society of Nuclear Medicine and Molecular Imaging and the Quantitative Medical Imaging Coalition have established a formal collaboration to ...
A Swedish clinical trial reveals that positron emission tomography with the PARP1-selective radiopharmaceutical AZ14193391 is feasible, safe, and delivers a ...
A systematic review of 22 clinical intervention trials reveals that FDG PET imaging consistently detects arterial inflammation reductions from statins, ...
Researchers have established standardized automated radiosynthesis protocols and quality control testing for two fluorine-18 labeled PET radiopharmaceuticals targeting alpha-synuclein pathologies ...
A study of 207 newly diagnosed Parkinson's disease patients reveals that glymphatic dysfunction associates with worse motor and cognitive symptoms, ...
Radiometal-labelled olaparib derivatives fail to cross cell membranes, rendering them unsuitable for targeted radionuclide therapy or PET imaging of intranuclear ...
A new review organizes CAR T-cell biomarker evidence in diffuse large B-cell lymphoma by assessment time and validation strength, concluding ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine